The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: Focus on macrophage polarization of THP-1 cells

•IFN-γ differentiates THP-1 cells to M1-type macrophages and upregulates IDO expression.•Over expression of IDO promotes M2-polarized THP-1 macrophages.•Effects of IDO-knockdown on the macrophage polarization of THP-1 cells. Macrophages can be divided into two groups as M1 and M2 phenotype. Our resu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular immunology 2014-05, Vol.289 (1-2), p.42-48
Hauptverfasser: Wang, Xian-Feng, Wang, Hong-Sheng, Wang, Hao, Zhang, Fan, Wang, Ke-Fang, Guo, Qiang, Zhang, Ge, Cai, Shao-Hui, Du, Jun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•IFN-γ differentiates THP-1 cells to M1-type macrophages and upregulates IDO expression.•Over expression of IDO promotes M2-polarized THP-1 macrophages.•Effects of IDO-knockdown on the macrophage polarization of THP-1 cells. Macrophages can be divided into two groups as M1 and M2 phenotype. Our results and other groups revealed that IFN-γ can up-regulate the IDO expression and differentiate THP-1 cells to M1 phenotype. Therefore we hypothesized that IDO may play potential roles in macrophage differentiation. Interesting, our results indicated that the ectopic IDO increases the expression of M2 markers such as IL-10 and CXCR4 while decreases the M1 markers such as CCR7 and IL-12p35. In contrast, the knockdown of IDO expression in THP-1 cells resulted in increased M1 markers and lower M2 markers. Our results suggested that the expression intensity of IDO modulates macrophages differentiation. These finding support the counter-regulatory role for IDO with regarding to the polarization of macrophages to restrain excessive or inappropriate immune activation in inflammatory or tumor microenvironment. It throws new light on the mechanisms about the immunosuppressive effect of IDO in tumor or inflammatory diseases.
ISSN:0008-8749
1090-2163
DOI:10.1016/j.cellimm.2014.02.005